These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. [Lymphocytes. Roles in cellular immunity and humoral immunity]. Golovtchenko AM; Raichvarg D Ann Biol Clin (Paris); 1975; 33(2):63-74. PubMed ID: 1080972 [TBL] [Abstract][Full Text] [Related]
46. Duration of circulating and secretory antibody and cell-mediated immunity following immunization. Waldman RH; Ganguly R Dev Biol Stand; 1975; 28():273-84. PubMed ID: 1126572 [TBL] [Abstract][Full Text] [Related]
47. [Clinical and immunological study of 2 cases of systemic candidiasis]. Prandi G; Lasagni A; Stefani B Boll Ist Sieroter Milan; 1976 Mar; 55(71):65-72. PubMed ID: 66059 [TBL] [Abstract][Full Text] [Related]
48. Immunological relationship between herpes simplex and varicella-zoster viruses demonstrated by complement-fixation, neutralization and fluorescent antibody tests. Schmidt NJ; Lennette EH; Magoffin RL J Gen Virol; 1969 Apr; 4(3):321-8. PubMed ID: 4306713 [No Abstract] [Full Text] [Related]
50. Immunologic aspects of human thyroid cancer. Humoral and cell-mediated immunity, and a trial of immunotherapy. Amino N; Pysher T; Cohen EP; Degroot LJ Cancer; 1975 Sep; 36(3):963-73. PubMed ID: 1182683 [TBL] [Abstract][Full Text] [Related]
51. Immunology of herpes simplex virus infection: relevance to herpes simplex virus vaccines and cervical cancer. Nahmias AJ; Shore SL; Kohl S; Starr SE; Ashman RB Cancer Res; 1976 Feb; 36(2 pt 2):836-44. PubMed ID: 766960 [TBL] [Abstract][Full Text] [Related]
52. Lymphocyte interferon production and transformation after Herpes simplex infections in humans. Rasmussen LE; Jordan GW; Stevens DA; Merigan TC J Immunol; 1974 Feb; 112(2):728-36. PubMed ID: 4360547 [No Abstract] [Full Text] [Related]
53. Subtly impaired humoral immunity predisposes to frequently recurring genital herpes simplex virus type 2 infection and herpetic neuralgia. Seppanen M; Meri S; Notkola IL; Seppala IJ; Hiltunen-Back E; Sarvas H; Lappalainen M; Valimaa H; Palikhe A; Valtonen VV; Lokki ML J Infect Dis; 2006 Sep; 194(5):571-8. PubMed ID: 16897653 [TBL] [Abstract][Full Text] [Related]
54. [Herpes virus hominis type 1 and mental diseases (author's transl)]. Dubay L; Hrbka A Cas Lek Cesk; 1976 Dec; 115(52):1614-7. PubMed ID: 1017009 [No Abstract] [Full Text] [Related]
55. Role of antibody in in vitro stimulation of lymphocytes. Kapoor AK; Khan IU; Bhushan V Indian J Exp Biol; 1983 Nov; 21(11):583-4. PubMed ID: 6327508 [No Abstract] [Full Text] [Related]
56. Mechanisms of allograft rejection. Hamburger J Trans Am Soc Artif Intern Organs; 1976; 22():729-33. PubMed ID: 781987 [No Abstract] [Full Text] [Related]
57. In vitro studies on the human cellular immune response to commercially available herpes simplex antigens. Czarnetzki BM; Macher E Arch Dermatol Res; 1980; 268(3):247-55. PubMed ID: 7212769 [TBL] [Abstract][Full Text] [Related]
58. [Sensitization against the antigens of the brain after experimental vaccinia infection. I. Evidence for cell-mediated immune response to brain-antigens (author's transl)]. Huber HC; Zinn KH; Hochstein-Mintzel V; Simon J; Stickl H Zentralbl Bakteriol Orig A; 1975 Jun; 232(1):1-7. PubMed ID: 51549 [TBL] [Abstract][Full Text] [Related]
59. Effects on cancer patients of leukapheresis with the continuous-flow blood cell separator. II. Immunologic parameters in vitro. Waldman SR; Roth JA; Kern DH; Pilch YH J Lab Clin Med; 1975 Dec; 86(6):950-61. PubMed ID: 127818 [TBL] [Abstract][Full Text] [Related]